Relay Therapeutics Inc is trading 6.5% down at $14.55 in pre-market as the stock undergoes a position reset following a significant multi-day rally.
- Shares had climbed approximately 11–12% over the last week prior to this morning's pullback.
- No fresh company-specific news, earnings reports, or analyst calls have emerged to drive the decline.
- Market observers characterize the move as normal profit-taking rather than a reaction to a new fundamental catalyst.